Combination of Heart-Health Drugs May Also Protect the Brain
Common blood pressure, cholesterol and diabetes drugs taken together linked to slower cognitive decline, with triple therapy showing the strongest brain health benefits.
All posts by Alzheimer's Association
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
SNAP Benefits Linked to Slower Cognitive Decline
SNAP food assistance linked to slower cognitive decline over 10 years, suggesting nutrition support may help protect brain health and delay dementia onset in older adults.
Clinical Practice Guideline for Blood-Based Biomarker Tests
Alzheimer’s Association clinical guideline for blood biomarker tests to aid faster, more accurate Alzheimer’s diagnosis in specialised memory care settings.
US Pointer Study: Lifestyle Program Boosts Cognition in At-Risk Adults
U.S. POINTER trial shows structured lifestyle changes can boost cognition and protect brain health in at-risk older adults, with benefits lasting up to 2 yrs
Lead Pollution Linked to Memory Problems in Older Adults
Historic lead exposure from the era of leaded petrol linked to 20% higher risk of memory problems in older adults, decades after initial exposure
Real-World Results for New Alzheimer’s Drugs Show Effectiveness
Real world data from AAIC 2025 shows Alzheimer’s drugs lecanemab and donanemab match or exceed clinical trial safety, with patients reporting positive outcomes.
New Insights Into Cognitive Health Differences Between Men and Women
AAIC 2025 research finds TBIs may shrink dementia-related brain areas more in women and links chemotherapy-related brain changes to memory and focus problems.
Have you booked your ticket for AAIC 2025?
Claim your early bird rate for the AAIC 2025 in Toronto by May 16 at 11:59 p.m. CT!
Join your colleagues at a Neuroscience Next Hub
AAIC® Neuroscience Next is a global, no-cost conference Feb. 24-27, 2025 that aims to support and showcase the next generation of Alzheimer’s and dementia researchers and clinicians.
Recommendations to Make Dementia Studies More Inclusive
New ISTAART PIA position paper to help researchers understand how best to partner with communities to encourage inclusive research.
ISTAART PIA Journal Clubs
ISTAART is excited to share that November is dedicated to ISTAART Journal Clubs. Ten Professional Interest Areas (PIAs) are hosting – register today
GLP-1 Drug Liraglutide May Protect Against Dementia
Research reported at AAIC shows a GLP-1 agonist — the class of drugs shown to help with diabetes and weight loss may also protect the brain.